22 Healthcare supply chain powered by SSI

 

Daniel Fritz and Marco Cuomo

    For many industries, tracking and monitoring the movement of goods in global supply chains is a key priority—and sometimes a regulatory requirement. Daniel Fritz and Marco Cuomo, innovation leaders at the Swiss-based pharmaceutical company Novartis, outline how their industry’s supply chain could be transformed—and how this can inspire other supply chain business leaders around the world to use SSI technologies.

    ■ ■ ■

    Доверяй, но проверяй (Trust, but verify)

    —Russian proverb adopted by President Ronald Reagan in nuclear disarmament treaty negotiations with the Soviet Union

    SSI will transform how supply chains operate—it is not a question of if, but when. A common, trusted, privacy-preserving approach for product and customer identification and transactions will reduce complexity, cost, and time. When broadly adopted, SSI will enable new business models for value-adding participants, resulting in benefits for local communities and the environment. Trusted end-to-end transparency for a supply chain is a good thing when considering a single industry. When SSI transforms several industries, the impact will not be just good—it can be a paradigm shift that can accelerate an industrial revolution.

    22.1 Emma’s story

    22.2 Supply chain transparency and efficiency through SSI

    22.3 Industry ecosystem efficiency powered by SSI

    22.4 Future supply chain transformation across industries: The big picture

    22.5 Eliminating waste

    22.6 Authentication and quality

    22.7 SSI Scorecard for the pharma supply chain

    References